scispace - formally typeset
P

Patrick Veit-Haibach

Researcher at University of Zurich

Publications -  195
Citations -  5714

Patrick Veit-Haibach is an academic researcher from University of Zurich. The author has contributed to research in topics: PET-CT & Medicine. The author has an hindex of 40, co-authored 165 publications receiving 5033 citations. Previous affiliations of Patrick Veit-Haibach include University Health Network.

Papers
More filters
Journal ArticleDOI

Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating

TL;DR: This first experience documents the feasibility of prospective ECG-gating for CTCA with diagnostic image quality at a low radiation dose, favouring HR <63 b.p.m. (P < 0.001).
Journal ArticleDOI

Zero TE MR bone imaging in the head.

TL;DR: To investigate proton density‐weighted zero TE (ZT) imaging for morphological depiction and segmentation of cranial bone structures, proton densities are measured through X-ray diffraction and radiolysis.
Journal ArticleDOI

EANM/EARL harmonization strategies in PET quantification: From daily practice to multicentre oncological studies

TL;DR: The validation of the EARL accreditation program to harmonize SUVs and MATVs is described in a wide range of tumor types, with focus on therapy assessment using either the European Organization for Research and Treatment of Cancer (EORTC) criteria or PET Evaluation Response Criteria in Solid Tumors (PERCIST), as well as liver-based scales such as the Deauville score.
Journal ArticleDOI

Influence of inter-observer delineation variability on radiomics stability in different tumor sites

TL;DR: Inter-observer delineation variability in manual tumor delineation has a relevant influence on radiomics analysis and is strongly influenced by tumor type, leading to a reduced number of suitable imaging features.
Journal ArticleDOI

Contrast-Enhanced 18F-FDG PET/CT: 1-Stop-Shop Imaging for Assessing the Resectability of Pancreatic Cancer

TL;DR: In this paper, the authors evaluated the value of combined contrastenhanced 18F-FDG PET/CT in assessing the resectability of pancreatic cancer and compared the performance of PET alone and unenhanced PET-CT.